Publications by authors named "D Fischman"
Objectives: Current thin-strut 2 generation drug eluting stents (DES) are considered as optimal standard of care for revascularization of coronary artery disease (CAD) patients undergoing percutaneous coronary intervention (PCI). Ultrathin (≤ 70 μm strut thickness) strut DES have recently been shown to reduce target lesion failure (TLF) compared to thin-strut DES. Therefore, in order to assess the validity of improved outcomes associated with ultrathin-strut DES, we conducted an updated meta-analysis that includes recently published follow-ups of previously conducted randomized controlled trials (RCTs).
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the best duration and choice of antiplatelet therapy for patients with acute coronary syndrome after undergoing percutaneous coronary intervention.
- A network meta-analysis was conducted on 32 trials with over 103,000 patients, comparing 12-month dual-antiplatelet therapy (DAPT) with several other strategies, including varying doses and durations.
- The findings suggest that the combination of aspirin and ticagrelor for 3 months, followed by aspirin and clopidogrel, significantly lowers major adverse cardiovascular events compared to other DAPT strategies.
Background: Atrial fibrillation (AF) is highly prevalent among cancer patients. The role of traditional risk stratification scores in the context of different cancer types in these patients remains unknown.
Objectives: The purpose of this study was to determine the discriminative accuracy of the CHADSVASc score for ischemic stroke using receiver operating characteristic and area under the curve.